A Glucose Clamp Trial Investigating the Biosimilarity of Gan & Lee Insulin Lispro Injection With Both EU - Approved and US - Licensed Humalog® in Healthy Male Subjects
Latest Information Update: 19 Oct 2023
At a glance
- Drugs Insulin lispro (Primary) ; Insulin lispro
- Indications Diabetes mellitus
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors Gan&Lee Pharmaceuticals
Most Recent Events
- 16 Oct 2023 Results presented in a Gan & Lee Pharmaceuticals media release.
- 13 Oct 2023 According to a Gan & Lee Pharmaceuticals media release, data from this study were presented at the peer-reviewed journal Diabetes, Obesity and Metabolism.
- 02 Jul 2021 According to a Gan & Lee Pharmaceuticals Co., Ltd media release, the abstract with phase 1 results have recently been published on the journal Diabetes website